Unibaio
Microparticle technology for a more sustainable agriculture
Mar del Plata, Argentina · Founded 2020 · $750K raised
- Headquarters
- Mar del Plata
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- unibaio.com
- Total Funding
- $750K
- Last Round
- $250K SeedDec 2024
- Rounds
- 3
About
Unibaio is an Argentinian biotechnology company that develops biodegradable microparticles based on natural polymers to improve the performance and sustainability of agrochemical inputs. Its proprietary delivery technology encapsulates active ingredients in pesticides, fertilizers, and phytosanitary products, enabling them to penetrate plant tissue more efficiently and reducing required application doses by up to 80%. Founded by a team of life scientists and economists, Unibaio operates across more than 35 crop types and 12 agrochemical categories, and has been backed by IndieBio, SF500, Grow-NY, and the UN Accelerator Program.
Summary
Unibaio is an Agtech company based in Mar del Plata, Argentina, founded in 2020. It has raised $750K in total across 3 rounds, most recently a $250K Seed round in Dec 2024. Investors include Ventures Platform.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
Leading North American energy infrastructure platform.
Self-driving cars.
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...